Get the Stockscreener App
23.82
0.85%
0.20
Pre-market:
24.54
0.72
+3.02%
Ceribell Inc stock is traded at $23.82, with a volume of 212.46K.
It is up +0.85% in the last 24 hours and down -0.50% over the past month.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
See More
Previous Close:
$23.62
Open:
$23.62
24h Volume:
212.46K
Relative Volume:
0.54
Market Cap:
$914.17M
Revenue:
$95.07M
Net Income/Loss:
$-60.37M
P/E Ratio:
-14.62
EPS:
-1.6291
Net Cash Flow:
$-50.92M
1W Performance:
-4.72%
1M Performance:
-0.50%
6M Performance:
+25.90%
1Y Performance:
+95.09%
1-Day Range:
$23.19
$23.90
1-Week Range:
$23.19
$25.31
52-Week Range:
$10.85
$25.63
Ceribell Inc Stock (CBLL) Company Profile
Name
Ceribell Inc
Sector
Industry
Phone
(800) 436-0826
Address
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
23.82 | 914.17M | 95.07M | -60.37M | -50.92M | -1.6291 |
ABT
Abbott Laboratories
|
101.07 | 174.89B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.51 | 113.22B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
269.75 | 103.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.68 | 64.75B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.73 | 49.41B | 6.30B | 1.07B | 1.09B | 1.8406 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Initiated | Raymond James | Strong Buy |
| Jun-24-25 | Initiated | BTIG Research | Buy |
| Apr-04-25 | Initiated | Ladenburg Thalmann | Buy |
| Nov-05-24 | Initiated | BofA Securities | Buy |
| Nov-05-24 | Initiated | Canaccord Genuity | Buy |
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Initiated | William Blair | Outperform |
View All
Ceribell Inc Stock (CBLL) Latest News
Ceribell stock price target reiterated at $30 by BTIG on growth outlook - Investing.com Nigeria
BTIG Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Blumberg Scott Executes 846 Ceribell Options and Disposes Shares on September 15, 2026 - Kalkine Media
CeriBell, Inc. (CBLL) Stock Analysis: Exploring the 12% Potential Upside in the Innovative Medical Device Sector - DirectorsTalk Interviews
Ceribell president and CEO Chao Xingjuan sells $521,775 in stock By Investing.com - Investing.com Nigeria
Ceribell president and CEO Chao Xingjuan sells $521,775 in stock - Investing.com
Ceribell CFO Scott Blumberg exercises options, sells $21,150 in stock. - Investing.com
Ceribell CFO Scott Blumberg exercises options, sells $21,150 in stock. By Investing.com - Investing.com Canada
Ceribell (CBLL) CEO sells stock under a preset 2025 trading plan - Stock Titan
Ceribell (CBLL) CFO sells 846 shares under 10b5-1 plan - stocktitan.net
CeriBell (CBLL) 10K Form and Latest SEC Filings 2026 - MarketBeat
Ceribell: Q2 Revenue Growth, FDA Clearances And NTAP Reimbursement In Focus - RTTNews
CeriBell, Inc.Common Stock (CBLL) Stock Price, News, Quote & History - FinancialContent
Ceribell CTO Raymond Woo sells $118,900 of company stock By Investing.com - Investing.com South Africa
BTIG reiterates Ceribell stock rating at buy, $30 price target By Investing.com - Investing.com South Africa
BTIG reiterates Ceribell stock rating at buy, $30 price target - Investing.com
Ceribell senior VP sells $224,451 of company stock By Investing.com - Investing.com Canada
Ceribell senior VP sells $224,451 of company stock - Investing.com
Ceribell CTO Raymond Woo sells $118,900 of company stock - Investing.com
Ceribell (CBLL) CTO trades stock under Rule 10b5-1 plan - stocktitan.net
Ceribell (CBLL) finance VP exercises options, sells stock under preset plan - Stock Titan
Ceribell CEO Chao Xingjuan Executes Options and Sells 39,540 Shares at $24.61, Retains 767,191 Shares - Kalkine Media
Electroencephalography Devices Market (2033): Tabletop EEG, - openPR.com
Ceribell CEO Chao Xingjuan sells $973,079 in company stock By Investing.com - Investing.com South Africa
Ceribell CFO Scott Blumberg sells $16,300 in common stock By Investing.com - Investing.com India
Ceribell CFO Scott Blumberg sells $16,300 in common stock - investing.com
Ceribell CEO Chao Xingjuan sells $973,079 in company stock - investing.com
Ceribell (CBLL) CEO sells nearly 40,000 shares under plan - stocktitan.net
CFO at Ceribell (CBLL) sells 652 shares under preset plan - Stock Titan
William Blair Maintains Ceribell(CBLL.US) With Buy Rating - Moomoo
Ceribell, Inc. (CBLL) Gets a Buy from Raymond James - The Globe and Mail
Raymond James raises Ceribell stock price target on new growth drivers - Investing.com Australia
Insiders At CeriBell Sold US$1.0m In Stock, Alluding To Potential Weakness - Moomoo
Ceribell (CBLL) CRO Joseph Manni sells $32,691 in shares By Investing.com - Investing.com India
Ceribell CFO Blumberg sells $36,534 in stock By Investing.com - Investing.com Nigeria
Ceribell CTO Raymond Woo sells $47,535 in company stock By Investing.com - Investing.com Nigeria
Ceribell president and CEO Chao Xingjuan sells $145,753 in stock By Investing.com - Investing.com Nigeria
Ceribell senior VP Foehr sells $44,424 in company stock By Investing.com - Investing.com Australia
Ceribell (CBLL) CFO sells 1,521 shares to cover taxes - Stock Titan
Ceribell CFO Scott Blumberg sells over $863k in company stock - Investing.com Nigeria
Ceribell Inc Stock (CBLL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.31%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):